PCVX - Vaxcyte, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
47.55 0.5 (1.04%) -0.02 (-0.03%) -0.13 (-0.26%) -0.88 (-1.79%) --- 0.5 (1.04%) --- ---

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.22
Diluted EPS:
-1.22
Basic P/E:
-39.3811
Diluted P/E:
-39.3811
RSI(14) 1m:
36.36
VWAP:
48.06
RVol:

Events

Period Kind Movement Occurred At

Related News